Venture
Harmony Biosciences II, Inc.
Latest Form D 2019-08-22- CIK 1718575
- State IL
- Pharmaceuticals
- 3 Form D offerings since 2017-10-06
- Total sold
- $345M
- across 3 offerings
- Rounds
- 3
- Form D offerings since 2017-10-06
- Latest round
- $50M
- 2019-08-22 · 021-347211
- Investors
- 30
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2019-08-22 · $50M
- 2017-10-06$270M021-296157
- 2018-01-18$25M021-303616
- 2019-08-22$50M021-347211
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($270M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-347211 | First filed2019-08-22 | Latest2019-08-22 | Sought$50M | Sold$50M | Investors30 | Exemptions506(b) |
| 021-303616 | First filed2018-01-18 | Latest2018-01-18 | Sought$25M | Sold$25M | Investors2 | Exemptions506(b) |
| 021-296157 | First filed2017-10-06 | Latest2017-10-06 | Sought$270M | Sold$270M | Investors29 | Exemptions506(b) |
Who backs Harmony Biosciences II, Inc. — 1 inferred investor — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2019-08-22
| Name | Relationship |
|---|---|
| PATRICK MORRIS | RelationshipExecutive Officer |
| JOHN JACOBS | RelationshipExecutive Officer, Director |
| JOHN VITTORIA | RelationshipExecutive Officer |
| ANDREW SERAFIN | RelationshipExecutive Officer |
| JEFFREY ARONIN | RelationshipDirector |
| ANTONIO GRACIAS | RelationshipDirector |
| JUAN SABATER | RelationshipDirector |
| JACK BECH NIELSEN | RelationshipDirector |
| MARTIN EDWARDS | RelationshipDirector |
| AARON ROYSTON | RelationshipDirector |
| DR. ANDREAS WICKI | RelationshipDirector |
| WILBUR GANTZ, III | RelationshipDirector |
| OCTAGON CAPITAL GROUP, LLC | RelationshipPromoter |
Sales compensation
Named in Item 12 of its Form D filings
| Recipient | CRD | Broker-dealer | Offerings |
|---|---|---|---|
| Octagon Capital Group, LLC | CRD173341 | Broker-dealer— | Offerings1 |
| OCTAGON CAPITAL GROUP, LLC | CRD173341 | Broker-dealer— | Offerings1 |
Facts
As its latest Form D states them
- Industry
- Pharmaceuticals
- State
- Illinois (IL)
- Exemptions
- Rule 506(b)
- First filed
- 2017-10-06
- Latest filing
- 2019-08-22
- Minimum investment
- $14K
Who backs Harmony Biosciences II, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗